A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).
Meyer RG, Britten CM, Siepmann U, Petzold B, Sagban TA, Lehr HA, Weigle B, Schmitz M, Mateo L, Schmidt B, Bernhard H, Jakob T, Hein R, Schuler G, Schuler-Thurner B, Wagner SN, Drexler I, Sutter G, Arndtz N, Chaplin P, Metz J, Enk A, Huber C, Wölfel T.
Meyer RG, et al. Among authors: britten cm.
Cancer Immunol Immunother. 2005 May;54(5):453-67. doi: 10.1007/s00262-004-0616-7. Epub 2004 Dec 31.
Cancer Immunol Immunother. 2005.
PMID: 15627214
Free PMC article.
Clinical Trial.